Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
作者： Priyamvada Jayaprakash , Midan Ai , Arthur Liu , Pratha Budhani , Todd Bartkowiak
DOI: 10.1172/JCI96268
关键词:
摘要: Despite the success of immune checkpoint blockade against melanoma, many “cold” tumors like prostate cancer remain unresponsive. We found that hypoxic zones were prevalent …
sci-hub.st 参考文章(41)
Milton J. Finegold, Francesco J. DeMayo, Roxani Angelopoulou, Norman M. Greenberg, Jeffrey M. Rosen, Brendan F. Boyce, Roberto J. Barrios, Ronald A. Morton, Jeffrey R. Gingrich, Metastatic Prostate Cancer in a Transgenic Mouse Cancer Research. ,vol. 56, pp. 4096- 4102 ,(1996)
Douglas Marvel, Dmitry I. Gabrilovich, Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected Journal of Clinical Investigation. ,vol. 125, pp. 3356- 3364 ,(2015) , 10.1172/JCI80005
Zhihu Ding, Chang-Jiun Wu, Gerald C. Chu, Yonghong Xiao, Dennis Ho, Jingfang Zhang, Samuel R. Perry, Emma S. Labrot, Xiaoqiu Wu, Rosina Lis, Yujin Hoshida, David Hiller, Baoli Hu, Shan Jiang, Hongwu Zheng, Alexander H. Stegh, Kenneth L. Scott, Sabina Signoretti, Nabeel Bardeesy, Y. Alan Wang, David E. Hill, Todd R. Golub, Meir J. Stampfer, Wing H. Wong, Massimo Loda, Lorelei Mucci, Lynda Chin, Ronald A. DePinho, SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression Nature. ,vol. 470, pp. 269- 273 ,(2011) , 10.1038/NATURE09677
Eugene D Kwon, Charles G Drake, Howard I Scher, Karim Fizazi, Alberto Bossi, Alfons J M van den Eertwegh, Michael Krainer, Nadine Houede, Ricardo Santos, Hakim Mahammedi, Siobhan Ng, Michele Maio, Fabio A Franke, Santhanam Sundar, Neeraj Agarwal, Andries M Bergman, Tudor E Ciuleanu, Ernesto Korbenfeld, Lisa Sengeløv, Steinbjorn Hansen, Christopher Logothetis, Tomasz M Beer, M Brent McHenry, Paul Gagnier, David Liu, Winald R Gerritsen, Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial Lancet Oncology. ,vol. 15, pp. 700- 712 ,(2014) , 10.1016/S1470-2045(14)70189-5
Gregory T Motz, Stephen P Santoro, Li-Ping Wang, Tom Garrabrant, Ricardo R Lastra, Ian S Hagemann, Priti Lal, Michael D Feldman, Fabian Benencia, George Coukos, Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nature Medicine. ,vol. 20, pp. 607- 615 ,(2014) , 10.1038/NM.3541
Stephen M. Hatfield, Jorgen Kjaergaard, Dmitriy Lukashev, Taylor H. Schreiber, Bryan Belikoff, Robert Abbott, Shalini Sethumadhavan, Phaethon Philbrook, Kami Ko, Ryan Cannici, Molly Thayer, Scott Rodig, Jeffrey L. Kutok, Edwin K. Jackson, Barry Karger, Eckhard R. Podack, Akio Ohta, Michail V. Sitkovsky, Immunological mechanisms of the antitumor effects of supplemental oxygenation. Science Translational Medicine. ,vol. 7, ,(2015) , 10.1126/SCITRANSLMED.AAA1260
Jasdeep K. Saggar, Man Yu, Qian Tan, Ian F. Tannock, The tumor microenvironment and strategies to improve drug distribution. Frontiers in Oncology. ,vol. 3, pp. 154- 154 ,(2013) , 10.3389/FONC.2013.00154
Peter Vaupel, Michael Höckel, Arnulf Mayer, Detection and characterization of tumor hypoxia using pO2 histography. Antioxidants & Redox Signaling. ,vol. 9, pp. 1221- 1235 ,(2007) , 10.1089/ARS.2007.1628
Jürgen C. Becker, Mads Hald Andersen, David Schrama, Per thor Straten, Immune-suppressive properties of the tumor microenvironment Cancer Immunology, Immunotherapy. ,vol. 62, pp. 1137- 1148 ,(2013) , 10.1007/S00262-013-1434-6
William R. Wilson, Michael P. Hay, Targeting hypoxia in cancer therapy Nature Reviews Cancer. ,vol. 11, pp. 393- 410 ,(2011) , 10.1038/NRC3064